|
Market Closed -
Other stock markets
|
After hours 01:00:00 | |||
| 61.82 USD | -2.11% |
|
58.02 | -6.15% |
| 07-16 | Moderna advances its cancer therapy assessment, but the stock slides |  |
| 07-16 | Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech -- Update | DJ |
| Market Cap | 24.53B 21.44B 19.78B 18.23B 34.37B 2,362B 35.13B 236B 92.99B 1,157B 92.12B 90.1B 3,983B | P/E 2026 * |
-7.13x | P/E 2027 * | -13x |
|---|---|---|---|---|---|
| Enterprise Value | 21.12B 18.46B 17.03B 15.7B 29.59B 2,034B 30.25B 204B 80.08B 996B 79.33B 77.59B 3,430B | EV / Sales 2026 * |
10.1x | EV / Sales 2027 * | 8.81x |
| Free-Float |
92.69% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Moderna, Inc.
| 1 day | -2.11% | ||
| 1 week | -9.45% | ||
| Current month | -11.72% | ||
| 1 month | +0.03% | ||
| 3 months | +15.08% | ||
| 6 months | +47.79% | ||
| Current year | +109.63% |
| 1 week | 61.06 |  | 69.55 |
| 1 month | 57.5 | | 85.6 |
| Current year | 29.81 | | 85.6 |
| 1 year | 22.28 | | 85.6 |
| 3 years | 22.28 | | 170.47 |
| 5 years | 22.28 | | 497.49 |
| 10 years | 11.54 | | 497.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Bancel
CEO | Chief Executive Officer | 54 | 28/02/2011 |
James Mock
DFI | Director of Finance/CFO | 49 | 05/09/2022 |
Stephen Hoge
PSD | President | 50 | 31/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Noubar Afeyan
CHM | Chairman | 63 | 31/01/2012 |
Stéphane Bancel
BRD | Director/Board Member | 54 | 28/02/2011 |
Francois Nader
BRD | Director/Board Member | 69 | 10/12/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/07/26 | Fiscal year | Chairperson | 160,008 | 0.0403% | ||
| 08/07/26 | Free | Director | 14,766 | 0.0037% | ||
| 05/07/26 | Free | Executive/Senior Manager | 57,022 | 0.0144% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.11% | -9.45% | +91.99% | -49.58% | 24.53B | |
| -0.33% | +1.83% | +23.03% | -6.22% | 68.85B | |
| +0.67% | +0.93% | +37.53% | +198.53% | 52.13B | |
| +0.94% | +39.60% | +39.60% | +39.60% | 43.46B | |
| +1.12% | +0.35% | -50.35% | -52.35% | 41.24B | |
| -1.40% | +3.43% | +60.07% | -26.01% | 30.41B | |
| +0.51% | +0.46% | +70.08% | +91.96% | 23.42B | |
| -5.57% | -0.84% | -0.17% | +174.11% | 19.75B | |
| -0.86% | -1.99% | +68.42% | +124.39% | 16.57B | |
| +1.34% | -5.25% | +74.11% | +154.00% | 15.95B | |
| Average | -0.57% | -1.25% | +41.43% | +64.84% | 33.63B | |
| Weighted average by Cap. | -0.26% | -0.31% | +33.37% | +52.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.1B 1.83B 1.69B 1.56B 2.94B 202B 3B 20.19B 7.94B 98.81B 7.87B 7.7B 340B | 2.55B 2.23B 2.06B 1.9B 3.57B 246B 3.65B 24.59B 9.67B 120B 9.58B 9.37B 414B |
| Net income | -3.41B -2.98B -2.75B -2.53B -4.78B -328B -4.88B -32.86B -12.93B -161B -12.8B -12.52B -554B | -1.85B -1.62B -1.49B -1.37B -2.59B -178B -2.65B -17.82B -7.01B -87.22B -6.94B -6.79B -300B |
| Net Debt | -3.41B -2.98B -2.75B -2.53B -4.77B -328B -4.88B -32.83B -12.91B -161B -12.79B -12.51B -553B | -2.05B -1.79B -1.66B -1.53B -2.88B -198B -2.94B -19.79B -7.78B -96.83B -7.71B -7.54B -333B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | US$61.82 | -2.11% | 4,551,991 |
| 16/07/26 | US$63.15 | -7.51% | 5,593,100 |
| 15/07/26 | US$68.28 | +1.25% | 3,427,825 |
| 14/07/26 | US$67.44 | +0.64% | 5,812,332 |
| 13/07/26 | US$67.01 | -1.85% | 8,521,959 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MRNA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
